Does ranolazine have a place in the treatment of acute coronary syndromes?

JAMA

Volumn 297, Issue 16, 2007, Pages 1823-1825

  Newby, L Kristin ^a   Peterson, Eric D ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANALGESIC AGENT; ANTIANGINA PECTORIS AGENT; ANXIOLYTIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DILTIAZEM; METOPROLOL; MORPHINE; NITRIC ACID DERIVATIVE; RANOLAZINE; SHORT ACTING DRUG; SODIUM;

ACUTE CORONARY SYNDROME; BRADYCARDIA; BRONCHOSPASM; CLINICAL FEATURE; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DEPRESSION; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; ERECTILE DYSFUNCTION; EXERCISE; FATIGUE; FOLLOW UP; HEART ARRHYTHMIA; HEART DISEASE; HEART MUSCLE ISCHEMIA; HOLTER MONITORING; HUMAN; INCIDENCE; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RARE DISEASE; RECURRENT DISEASE; ST SEGMENT DEPRESSION; SURVIVAL; SYNCOPE; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

EID: 34247485390     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.297.16.1823     Document Type: Editorial

References (15)

1. Chaitman BR. Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions. Circulation. 2006;113:2462-2472.
2. Belardinelli L, Shryock JC, Fraser H. Inhibition of the late sodium current as a potential cardioprotective principle. Heart. 2006;92(suppl 4):iv6-iv14.
3. Chaitman BR, Pepine CJ, Parker JO, et al; Combination Assessment of Ranolazine in Stable Angina (CARISA) Investigators. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina. JAMA. 2004;291:309-316.
4. Stone PH, Gratsiansky NA, Blokin A, Huang IZ, Meng L. Antianginal efficacy of ranolazine when added to treatment with amlodipine. J Am Coll Cardiol. 2006;48:566-575.
5. US Food and Drug Administration http://www.fda.gov/ohrms/dockets/ac/03/ briefing/4012B2_01_Action%20Letter.pdf. Accessibility verified April 4, 2007.
6. Morrow DA, Scirica BM, Karwatowska-Prokopczuk E, et al; MERLIN-TIMI 36 Trial Investigators. Effects of ranolazine on recurrent cardiovascular events in patients with non?ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial. JAMA. 2007;297:1775-1783.
7. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction. Prog Cardiovasc Dis. 1985;27:335-371.
8. Chen ZM, Pan HC, Chen YP, et al; COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) Collaborative Group. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet. 2005;366:1622-1632.
9. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet. 1994;343:1115-1122.
10. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet. 1995;345:669-685.
11. Gibbons RJ, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina. http://www.acc.org/ clinical/guidelines/stable/stable.pdf. Accessed March 28, 2007.
12. Meine TJ, Roe MT, Chen AY, et al; CRUSADE Investigators. Association of intravenous morphine use and outcomes in acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. Am Heart J. 2005;149:1043-1049.
13. Hirsch A, Windhausen F, Tijssen JG, et al; Invasive versus Conservative Treatment in Unstable Coronary Syndromes (ICTUS) Investigators. Long-term outcome after an early invasive versus selective invasive treatment strategy in patients with non-ST-elevation acute coronary syndrome and elevated cardiac troponin T (the ICTUS trial): a follow-up study. Lancet. 2007;369:827-835.
14. de Winter RJ, Windhausen F, Cornel JH, et al; Invasive versus Conservative Treatment in Unstable Coronary Syndromes (ICTUS) Investigators. Early invasive versus selectively invasive management for acute coronary syndromes. N Engl J Med. 2005;353:1095-1104.
15. Boden WE, O'Rourke RA, Teo KK, et al; COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease [published online ahead of print March 26, 2007]. N Engl J Med. doi:10.1056/NEJMoa070829.